A. Bratlie

895 total citations
36 papers, 744 citations indexed

About

A. Bratlie is a scholar working on Immunology, Transplantation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A. Bratlie has authored 36 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 11 papers in Transplantation and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A. Bratlie's work include T-cell and B-cell Immunology (12 papers), Renal Transplantation Outcomes and Treatments (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). A. Bratlie is often cited by papers focused on T-cell and B-cell Immunology (12 papers), Renal Transplantation Outcomes and Treatments (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). A. Bratlie collaborates with scholars based in Norway, Denmark and Singapore. A. Bratlie's co-authors include Erik Thorsby, Frode Vartdal, Gustav Gaudernack, J. Ugelstad, Steinar Funderud, T. Lea, Bjarte G. Solheim, Kristian Hannestad, D Albrechtsen and Torolf Moen and has published in prestigious journals such as Transplantation, Acta Obstetricia Et Gynecologica Scandinavica and Immunogenetics.

In The Last Decade

A. Bratlie

35 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Bratlie Norway 14 400 128 109 95 93 36 744
A Svejgaard Denmark 16 411 1.0× 58 0.5× 105 1.0× 48 0.5× 83 0.9× 41 831
H Festenstein United Kingdom 19 540 1.4× 111 0.9× 124 1.1× 144 1.5× 138 1.5× 66 1.0k
Byron P. Croker United States 15 253 0.6× 95 0.7× 42 0.4× 79 0.8× 108 1.2× 24 637
S. Yoon Choo United States 12 518 1.3× 72 0.6× 124 1.1× 43 0.5× 103 1.1× 24 805
V. Joysey United Kingdom 16 365 0.9× 85 0.7× 216 2.0× 179 1.9× 74 0.8× 33 809
S. F. Goldmann Germany 13 469 1.2× 104 0.8× 278 2.6× 28 0.3× 113 1.2× 54 863
Neubury M. Lardy Netherlands 18 566 1.4× 63 0.5× 165 1.5× 108 1.1× 114 1.2× 47 911
M. J. Giphart Netherlands 18 616 1.5× 92 0.7× 86 0.8× 30 0.3× 96 1.0× 45 937
H. Dunckley Australia 21 729 1.8× 115 0.9× 122 1.1× 158 1.7× 102 1.1× 73 1.2k
M. M. Tongio France 15 425 1.1× 76 0.6× 113 1.0× 26 0.3× 74 0.8× 39 617

Countries citing papers authored by A. Bratlie

Since Specialization
Citations

This map shows the geographic impact of A. Bratlie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bratlie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bratlie more than expected).

Fields of papers citing papers by A. Bratlie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bratlie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bratlie. The network helps show where A. Bratlie may publish in the future.

Co-authorship network of co-authors of A. Bratlie

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bratlie. A scholar is included among the top collaborators of A. Bratlie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bratlie. A. Bratlie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bratlie, A., et al.. (1997). Characterization of a novel HLA‐B allele, B*0804, in a Norwegian family. Tissue Antigens. 50(3). 308–310. 4 indexed citations
2.
Leivestad, T., A. Foerster, Svein Simonsen, et al.. (1996). HLA-DR matching reduces rejection rate in heart transplantation. Transplant International. 9 Suppl 1. 230–233. 2 indexed citations
3.
Bratlie, A., et al.. (1995). A human hybridoma monoclonal antibody (TrJ11) recognizing a new HLA-DR epitope shared by DR4, DR8, DR11, and DRB1∗1303. Human Immunology. 42(1). 27–34. 5 indexed citations
4.
Bratlie, A., et al.. (1992). A cytotoxic monoclonal human hybridoma antibody (TrJ3) against HLA‐B44(12) and ‐B45(12). Tissue Antigens. 39(5). 258–261. 7 indexed citations
5.
Albrechtsen, D, A. Bratlie, Anders Jakobsen, et al.. (1990). The role of HLA compatibility in renal transplantation from living donors: an analysis of 379 grafts.. PubMed. 22(1). 153–153. 2 indexed citations
6.
Hansen, Thomas Folkmann, A. Bratlie, Bjarne Johansen, & Kristian Hannestad. (1989). Two cytotoxic human‐human hybridoma antibodies to HLA: TrAH10 (anti A3.1) and TrAG2 (anti B7,Bw42). Tissue Antigens. 33(5). 520–530. 6 indexed citations
7.
Bratlie, A., et al.. (1989). A cytotoxic human‐human hybridoma antibody (TrC7) specific for HLA‐A29. Tissue Antigens. 33(5). 542–545. 11 indexed citations
8.
Hansen, Thomas Folkmann, A. Bratlie, & Kristian Hannestad. (1988). Four cytotoxic human‐human hybridoma antibodies that react with HLA‐B27. Tissue Antigens. 32(5). 267–277. 12 indexed citations
9.
Bratlie, A., et al.. (1986). HLA genotypes in a family with a case of homozygous C2 deficiency and discoid lupus erythematosus. Acta Dermato Venereologica. 66(5). 419–422. 6 indexed citations
10.
Vartdal, Frode, Gustav Gaudernack, Steinar Funderud, et al.. (1986). HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation ‐ a fast and reliable technique. Tissue Antigens. 28(5). 301–312. 249 indexed citations
11.
Moen, Mette Haase, et al.. (1984). Distribution of HLA‐antigens among patients with endometriosis. Acta Obstetricia Et Gynecologica Scandinavica. 63(S123). 25–27. 28 indexed citations
12.
Moen, Torolf, et al.. (1984). Distribution of HLA‐SB antigens in multiple sclerosis. Tissue Antigens. 24(2). 126–127. 25 indexed citations
13.
Moen, Torolf, et al.. (1983). Identification of four SB antigens by cloned cells: Population studies of Norwegians. Tissue Antigens. 22(4). 298–309. 28 indexed citations
15.
Gedde‐Dahl, Tobias, et al.. (1978). Pepsinogens: new variant and linkage relationships to chromosome 6 markers. Cytogenetic and Genome Research. 22(1-6). 301–303. 7 indexed citations
16.
Olaisen, B., et al.. (1978). Structural complement factor loci and the HLA region. Cytogenetic and Genome Research. 22(1-6). 421–427. 14 indexed citations
17.
Solheim, Bjarte G., J. Ek, P Thune, et al.. (1976). HLA Antigens in Dermatitis Herpetiformis and Coeliac Disease. Tissue Antigens. 7(1). 57–59. 50 indexed citations
18.
Thorsby, Erik, et al.. (1971). The HL‐A System: Antigenic Heterogeneity and Four New Antigens. Tissue Antigens. 1(1). 32–38. 20 indexed citations
19.
Svejgaard, Arne, A. Bratlie, Claes F. Högman, et al.. (1971). The Recombination Fraction of the HL‐A System. Tissue Antigens. 1(2). 81–88. 49 indexed citations
20.
Thorsby, Erik, et al.. (1970). Cross‐Reactive HL‐A Antibodies; Absorption and Immunization Studies. Vox Sanguinis. 18(4). 373–378. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026